OnKure Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
340
across all filing types
Latest filing
2026-04-24
Regulatory Filings
Country
US
United States of America
Listing
US
OKUR
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines for cancer patients. The company is building a pipeline of potentially best-in-class, tumor-agnostic therapies that target biologically validated drivers of cancers, particularly those underserved by current treatments. Its research and development efforts are centered on novel and potentially less toxic kinase inhibitor drugs and epigenetic therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-04-24 | English | |
| 8-K - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-03-30 | English | |
| 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | |
| 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 36258748 | S-3 - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-04-24 | English | ||
| 33086632 | 8-K - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-03-30 | English | ||
| 33035819 | 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | ||
| 33035817 | 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | ||
| 31048892 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31048890 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31048889 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 12862905 | 4 | 2026-01-02 | English | ||
| 12862904 | Director's Dealing 2026 | 2026-01-02 | English | ||
|
2025
6 filings
| |||||
| 12862906 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12862907 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12862908 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 12862909 | 424B3 | 2025-11-21 | English | ||
| 12862910 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 12862913 | POS AM | 2025-11-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
OnKure Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OnKure Therapeutics, Inc. (id: 34730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.